CliffBio
small molecule

PEDIATRIC ADVIL

IBUPROFEN

Loss of exclusivity—loss of exclusivity
CompanyHaleon →See this company's full patent-cliff portfolio

Drug detail

Brand namePEDIATRIC ADVIL
Active ingredientIBUPROFEN
Strength100MG/2.5ML
Dosage formSUSPENSION/DROPS
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 1998
Marketing statusDISCN

More from Haleon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.